What Is JNJ Fair Value?
Johnson & Johnson (JNJ) fair value estimate using multiple valuation models, updated daily.
As of October 31, 2026, Johnson & Johnson (JNJ) has a composite fair value estimate of $179.79 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $273.20, suggesting the stock is overvalued by 34.2%.
Data as of October 31, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$179.79
vs. current price of $273.20(-34.2%)
How Is JNJ Fair Value Calculated?
Four independent models estimate what JNJ is worth. Each uses different inputs and assumptions. The composite blends them by weight.
JNJ Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$258.41
-5.4%Fair Value
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$150.49
-44.9%Overvalued
Inputs used
JNJ Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$92.05
-66.3%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$111.20
-59.3%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $273.20 is 5.4% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $20.86B | $19.77B |
| Year 2 | $21.65B | $19.44B |
| Year 3 | $22.46B | $19.12B |
| Year 4 | $23.31B | $18.80B |
| Year 5 | $24.19B | $18.49B |
| Year 6 | $25.10B | $18.18B |
| Year 7 | $26.05B | $17.88B |
| Year 8 | $27.03B | $17.58B |
| Year 9 | $28.05B | $17.29B |
| Year 10 | $29.11B | $17.00B |
| Terminal Value | $985.90B | $575.76B |
What Are JNJ's Key Financial Metrics?
Earnings & Growth
Current Price
$273.20
EPS (TTM)
$6.59
Forward P/E
23.5
Profit Margin
16.2%
Cash & Balance Sheet
Free Cash Flow
18.5B
EBITDA
34.5B
Book Value
$33.87
Total Debt
44.7B
What Do Analysts Say About JNJ?
Low
$190.00
Average
$279.41
High
$320.00
Upside
+2.3%
JNJ Fair Value FAQ
What is the fair value of JNJ?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), JNJ's estimated fair value is $179.79. The stock is currently trading at $273.20, which makes it overvalued by our analysis.
How is JNJ's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is JNJ overvalued or undervalued?
Based on our analysis, JNJ is overvalued. The current price of $273.20 is 34.2% above our estimated fair value of $179.79.
What do Wall Street analysts say about JNJ?
22 analysts cover Johnson & Johnson with a consensus rating of "Buy." The average price target is $279.41, ranging from $190.00 to $320.00. This implies 2.3% upside from the current price.